Meeting
2018 Genitourinary Cancers Symposium
Evaluation of a 29 gene classifier for basal/non basal prediction in muscle-invasive bladder cancer FFPE samples.
Authors
Yves Allory
Henri Mondor Hospital, Créteil, France
Yves Allory , Nanor Sirab , Damien Drubay , David Gentien , Aurélien De Reyniès , Benoit Albaud , Aurélie Kamoun , Pascale Soyeux , Pascale Maille , Thierry Lebret , Simone Benhamou , Xavier Paoletti , Francois Radvanyi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 467)
DOI
10.1200/JCO.2018.36.6_suppl.467
Abstract #
467
Poster Bd #
H16
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Prediction of response to neoadjuvant chemotherapy of patients with muscle invasive bladder cancer by molecular subtyping and radioligand target quantitation: Preview of the Bladder BRIDGister.
First Author: Ralph M. Wirtz
Poster
2020 Genitourinary Cancers Symposium
Association of an immune gene signature with pathologic response and outcome after neoadjuvant pembrolizumab (pembro), compared to neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (MIBC).
First Author: Andrea Necchi
Poster
2018 Genitourinary Cancers Symposium
A genomic classifier for identifying a neuroendocrine-like bladder cancer subtype.
First Author: Jonathan L. Wright
Poster
2016 Genitourinary Cancers Symposium
Molecular tumor grading of non muscle invasive bladder cancer based on whole transcriptome analysis.
First Author: Jess Shen